Daniella Beckman

Daniella Beckman

Former Chief Financial OfficeratTango Therapeutics· In proxies 2022–2025

Pay in FY2025-63% from the year before · Tango Therapeutics stock +186.7% the same year

Daniella Beckman was paid $1.2M in FY2025 (Dec), down 63%. Tango Therapeutics stock rose 186.7% that year.

Pay$100 in the stock at the end of FY21 → $81
Pay is from the Summary Compensation Table of each Tango Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tango TherapeuticsPublic company · 4 yr
    • Former Chief Financial Officer2022 – Present · 4 yrStock in role +107%
  2. Vor BiopharmaPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Blueprint Medicines CorpPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  4. Translate Bio, Inc.Public company · 9 yr
    • Director2017 – Present · 9 yrNo stock prices for these years
  5. 5:01 Acquisition CorpPublic company
    • Director? – PresentNo stock prices for these years
  6. Acquisition CorpPublic company · 2 yr
    • Director2020 – 2022 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Vor BiopharmaDirector · 4 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?